- Home
- XBIO vs IMTE Comparison
XBIO vs IMTE Comparison
Compare XBIO & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- IMTE
- Stock Information
- Founded
- XBIO N/A
- IMTE 2008
- Country
- XBIO United States
- IMTE Malaysia
- Employees
- XBIO N/A
- IMTE N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- XBIO Health Care
- IMTE Consumer Staples
- Exchange
- XBIO Nasdaq
- IMTE Nasdaq
- Market Cap
- XBIO 6.3M
- IMTE 5.3M
- IPO Year
- XBIO N/A
- IMTE N/A
- Fundamental
- Price
- XBIO $4.03
- IMTE $1.26
- Analyst Decision
- XBIO Hold
- IMTE
- Analyst Count
- XBIO 1
- IMTE 0
- Target Price
- XBIO N/A
- IMTE N/A
- AVG Volume (30 Days)
- XBIO 4.8K
- IMTE 6.4K
- Earning Date
- XBIO 03-20-2025
- IMTE 03-04-2025
- Dividend Yield
- XBIO N/A
- IMTE N/A
- EPS Growth
- XBIO N/A
- IMTE N/A
- EPS
- XBIO N/A
- IMTE N/A
- Revenue
- XBIO $2,523,427.00
- IMTE $123,337.00
- Revenue This Year
- XBIO N/A
- IMTE N/A
- Revenue Next Year
- XBIO N/A
- IMTE N/A
- P/E Ratio
- XBIO N/A
- IMTE N/A
- Revenue Growth
- XBIO 7.15
- IMTE 4.75
- 52 Week Low
- XBIO $2.78
- IMTE $1.06
- 52 Week High
- XBIO $5.20
- IMTE $3.84
- Technical
- Relative Strength Index (RSI)
- XBIO 45.61
- IMTE 47.80
- Support Level
- XBIO $3.91
- IMTE $1.21
- Resistance Level
- XBIO $4.24
- IMTE $1.30
- Average True Range (ATR)
- XBIO 0.17
- IMTE 0.07
- MACD
- XBIO -0.01
- IMTE -0.00
- Stochastic Oscillator
- XBIO 28.93
- IMTE 30.16
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.